(Q36268846)

13 August 2017

1 reference

title

Strategies for the development of new antiarthritic agents (English)

1 reference

13 August 2017

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

16 October 2022

author name string

Molnar-Kimber KL

4

1 reference

13 August 2017

A. J. Lewis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618601

16 October 2022

K. B. Glaser

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618601

16 October 2022

R. J. Sturm

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618601

16 October 2022

K. L. Molnar-Kimber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618601

16 October 2022

C. C. Bansbach

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1618601

16 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1618601

16 October 2022

publication date

1 April 1992

1 reference

full work available at URL

13 August 2017

https://api.elsevier.com/content/article/PII:019205619290181J?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

https://api.elsevier.com/content/article/PII:019205619290181J?httpAccept=text/plain

16 October 2022

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

International Journal of Immunopharmacology

16 October 2022

published in

1 reference

13 August 2017

volume

14

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

497-504

1 reference

Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen–Ia complex

13 August 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Increased expression of p150,95 and CR3 leukocyte adhesion molecules by mononuclear phagocytes in rheumatoid synovial membranes. Comparison with osteoarthritic and normal synovial membranes

16 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

16 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Eicosanoids and rheumatology: inflammatory and vascular aspects

16 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins

16 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Inhibition of 5-lipoxygenase product formation and polymorphonuclear cell degranulation by tenidap sodium in patients with rheumatoid arthritis

16 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Carbohydrate ligands of the LEC cell adhesion molecules

16 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Nonsteroidal antiinflammatory drugs--differences and similarities

16 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Membrane proteins involved in phagocyte adherence to endothelium

16 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Phospholipase A2: function and pharmacological regulation

16 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Regulation of alloreactivity in vivo by a soluble form of the interleukin-1 receptor

16 October 2022

16

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

How important are T cells in chronic rheumatoid synovitis?

16 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

16 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase

16 October 2022

20

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

The V-region disease hypothesis: evidence from autoimmune encephalomyelitis

16 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Absence of modulation of monokine production via endogenous cyclooxygenase or 5-lipoxygenase metabolites: MK-886 (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2- dimethylpropanoic acid), indomethacin, or arachidonate fail to alter i

16 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides

16 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

16 October 2022

The leukocyte integrins

25

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Immunolocalization of endothelial and leukocyte adhesion molecules in human rheumatoid and osteoarthritic synovial tissues

16 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules

16 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

ELAM-1-dependent cell adhesion to vascular endothelium determined by a transfected human fucosyltransferase cDNA

16 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

16 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Evidence for the effects of a superantigen in rheumatoid arthritis

16 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

ELAM-1 Mediates Cell Adhesion by Recognition of a Carbohydrate Ligand, Sialyl-Le x

16 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Disease modifying drugs for rheumatoid arthritis: yesterday's treatment today or today's treatment tomorrow?

16 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Chemistry and Biology of the Immunophilins and Their Immunosuppressive Ligands

16 October 2022

40

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Adhesion receptors of the immune system

16 October 2022

41

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

16 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

Association of HLA–Dw16 with rheumatoid arthritis in Yakima Indians. Further evidence for the “shared epitope” hypothesis

16 October 2022

46

1 reference

https://api.crossref.org/works/10.1016/0192-0561(92)90181-J

16 October 2022

Identifiers

1 reference

13 August 2017

1 reference